Volume 89, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



A cholera epidemic has claimed the lives of more than 8,000 Haitians and sickened 650,000 since the outbreak began in October 2010. Early intervention in the epidemic focused on case-finding, treatment, and water and sanitation interventions for prevention of transmission. Use of oral cholera vaccine (OCV) as part of a complementary set of control activities was considered but initially rejected by policymakers. In December 2011, the Minister of Health of Haiti called for a demonstration of the acceptability and feasibility of the use of OCV in urban and rural Haiti. This paper describes the collaborative activity that offered OCV to one region of the Artibonite Department of rural Haiti in addition to other ongoing treatment and control measures. Despite logistics and cold chain challenges, 45,417 persons were successfully vaccinated with OCV in the region, and 90.8% of these persons completed their second dose.

[open-access] This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Ministère de la Santé et de la Population, 2013. Rapport de Cas 24 Mars 2013. Available at: http://www.mspp.gouv.ht/site/index.php?option=com_content&view=article&id=120&Itemid=1. Accessed March 30, 2013. [Google Scholar]
  2. Pan-American Health Organization, 2013. PAHO/WHO Calls for International Funding of New Haiti Cholera Plan. Available at: http://reliefweb.int/report/haiti/pahowho-calls-international-funding-new-haiti-cholera-plan. Accessed March 30, 2013. [Google Scholar]
  3. World Health Organization, 2013. Prevention and Control of Cholera Outbreaks: WHO Policy and Recommendations. Available at: http://www.who.int/cholera/technical/prevention/control/en/index.html. Accessed March 30, 2013. [Google Scholar]
  4. Date KA, Vicari A, Hyde TB, Mintz E, Danovaro-Holliday MC, Henry A, Tappero JW, Roels TH, Abrams J, Burkholder BT, Ruiz-Matus C, Andrus J, Dietz V, , 2011. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010–2011. Emerg Infect Dis 17: 21052112.[Crossref] [Google Scholar]
  5. Daniel T, , 2011. New Cholera Campaign Faces Tough Questions. Associated Press: November 9, 2011. Available at: http://www.usatoday.com/news/health/story/health/story/2011-11-09/New-Haiti-cholera-campaign-faces-tough-questions/51136304/1. Accessed March 30, 2013. [Google Scholar]
  6. Knox R, , 2010. Cholera Vaccine Isn't the Answer for Haiti. NPR: October 28, 2010. Available at: http://www.npr.org/blogs/health/2010/10/28/130884642/why-the-cholera-vaccine-isn-t-the-answer-for-haiti. Accessed March 30, 2013. [Google Scholar]
  7. Ivers LC, Farmer P, Almazor CP, Léandre F, , 2010. Five complementary interventions to slow cholera. Lancet 376: 20482051.[Crossref] [Google Scholar]
  8. Farmer P, Almazor CP, Bahnsen ET, Barry D, Bazile J, Bloom BR, Bose N, Brewer T, Calderwood SB, Clemens JD, Cravioto A, , 2011. Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care. PLoS Negl Trop Dis 5: e1145.[Crossref] [Google Scholar]
  9. World Health Organization, 2010. Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 85: 117128. [Google Scholar]
  10. Ali M, Emch M, Seidlein L, Yunus M, Sack D, Rao M, Homgren J, Clemens JD, , 2005. Herd immunity conferred by killed oral cholera vaccines: a reanalysis. Lancet 366: 4449.[Crossref] [Google Scholar]
  11. World Health Organization, 2010. Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 85: 117128. [Google Scholar]
  12. Ministère de la Santé et de la Population, 2013. Rapport de Cas 31 Décembre 2011. Available at: http://www.mspp.gouv.ht/site/index.php?option=com_content&view=article&id=120&Itemid=1. Accessed March 30, 2013. [Google Scholar]
  13. Ministère de la Santé et de la Population, 2013. Rapport de Cas Par Semaine Épidémiologique. Available at: http://www.mspp.gouv.ht/site/index.php?option=com_content&view=article&id=119&Itemid=1. Accessed March 30, 2013. [Google Scholar]
  14. World Bank, 2013. Haiti Fact Sheet. Available at: http://www.worldbank.org/en/country/haiti/overview. Accessed March 30, 2013. [Google Scholar]
  15. Barzilay EJ, Schaad N, Magloire R, Mung KD, Boncy J, Dahourou GA, Mintz ED, Steenland MW, Vertefeuille J, Tappero JW, , 2013. Cholera surveillance during the Haiti epidemic: the first 2 years. N Engl J Med 368: 599609.[Crossref] [Google Scholar]
  16. Partners In Health, 2013. Facilitator Manual, Participant Handbook. Available at: http://www.pih.org/publications/entry/community-health-worker-cholera-training-manuals. Accessed August 19, 2013. [Google Scholar]
  17. Emch M, Ali M, Jin-Kyung P, Yunus M, Sack DA, Clemens JD, , 2006. Relationship between neighborhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity. Int J Epidemiol 35: 10441050.[Crossref] [Google Scholar]
  18. Jeuland M, Cook J, Poulos C, Clemens J, Whittington D, , 2009. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. ISPOR 12: 899908. [Google Scholar]
  19. Griffith DC, Kelly-Hope LA, Miller MA, , 2006. Review of reported cholera outbreaks worldwide, 1995–2005. Am J Trop Med Hyg 75: 973977. [Google Scholar]
  20. Saha A, Chowdhury MI, Khanam F, Bhuiyan S, Chowdhury F, Khan AI, Khan IA, Clemens J, Ali M, Cravioto A, Qadri F, , 2011. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine 29: 82858292.[Crossref] [Google Scholar]
  21. Hashim R, Khatib AM, Enwere G, Park JK, Reyburn R, Ali M, Chang NY, Kim DR, Ley B, Thriemer K, Lopez AL, Clemens JD, Deen DJ, Shin S, Schaetti C, Hutubessv R, Aguado MT, Kieny MP, Sack D, Obaro S, Shaame AJ, Ali SM, Saleh AA, von Seidlein L, Jiddawi MS, , 2012. Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy. PLoS Negl Trop Dis 6: e1743.[Crossref] [Google Scholar]
  22. Chao DL, Halloran ME, Longini IM, , 2011. Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proc Natl Acad Sci USA 108: 70817085.[Crossref] [Google Scholar]
  23. Mukandavire Z, Liao S, Wang J, Gaff H, Smith DL, Morris JG, , 2011. Estimating the reproductive numbers for the 2008–2009 cholera outbreaks in Zimbabwe. Proc Natl Acad Sci USA 108: 87678772.[Crossref] [Google Scholar]
  24. Reyburn R, Deen JL, Grais RF, Bhattacharya SK, Sur D, Lopez AL, Jiddawi MS, Clemens JD, von Seidlein L, , 2011. The case for reactive mass oral cholera vaccinations. PLoS Negl Trop Dis 5: e952.[Crossref] [Google Scholar]
  25. Anh DD, Lopez AL, Thiem VD, Grahek SL, Duong TN, Park JK, Kwon HJ, Favorov M, Hien NT, Clemens JD, , 2011. Use of oral cholera vaccines in an outbreak in Vietnam: a case control study. PLoS Negl Trop Dis 5: e1006.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 08 Apr 2013
  • Accepted : 08 May 2013
  • Published online : 09 Oct 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error